- ProductsInvestment SuiteExclusiveFeatures
- PlatformTrading PlatformsFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketMarket MoversStocksIndicesMutual FundsIPO
- LearnStockshaalaResourceInvesting GuideEvents
- Partner
- Support
Products
Platform
Research
Market
Learn
Compare Nippon India Pharma Fund vs SBI Healthcare Opportunities Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 1.8 | 1.93 |
NAV | ₹506.58 | ₹417.66 |
Fund Started | 10 May 2004 | 04 Jun 1999 |
Fund Size | ₹8352.16 Cr | ₹3689.28 Cr |
Exit Load | Exit load of 1% if redeemed within 1 month. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹100
₹500
Expense Ratio
1.8
1.93
NAV
₹506.58
₹417.66
Fund Started
10 May 2004
04 Jun 1999
Fund Size
₹8352.16 Cr
₹3689.28 Cr
Exit Load
Exit load of 1% if redeemed within 1 month.
Exit load of 0.50% if redeemed within 15 days
Returns
1 Year | 13.81% | 17.30% |
3 Year | 25.69% | 28.86% |
5 Year | 21.73% | 23.38% |
1 Year
13.81%
17.30%
3 Year
25.69%
28.86%
5 Year
21.73%
23.38%
Holding Analysis
Equity | 98.60% | 96.09% |
Cash | 1.40% | 3.83% |
Equity
98.60%
96.09%
Cash
1.40%
3.83%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.57% |
Divi's Laboratories Ltd. | 9.49% |
Lupin Ltd. | 5.82% |
Cipla Ltd. | 5.62% |
Dr. Reddy's Laboratories Ltd. | 5.49% |
Apollo Hospitals Enterprise Ltd. | 5.34% |
Medplus Health Services Ltd. | 4.20% |
Glaxosmithkline Pharmaceuticals Ltd. | 3.73% |
Vijaya Diagnostic Centre Ltd. | 3.24% |
Narayana Hrudayalaya Ltd. | 2.94% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.73% |
Divi's Laboratories Ltd. | 7.39% |
Max Healthcare Institute Ltd. | 6.40% |
Lonza Group Ag | 4.81% |
Cipla Ltd. | 4.77% |
Lupin Ltd. | 4.46% |
Mankind Pharma Ltd. | 3.75% |
Krishna Institute of Medical Sciences Ltd | 3.34% |
Fortis Healthcare Ltd. | 3.22% |
Acutaas Chemicals Ltd. | 3.19% |
Fund Manager
Name | Akshay Sharma | Tanmaya Desai |
Start Date | 01 Dec 2022 | 27 Jun 2011 |
Name
Akshay Sharma
Tanmaya Desai
Start Date
01 Dec 2022
27 Jun 2011
About Fund
Description | The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 10 May 2004 | 04 Jun 1999 |
Description
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
10 May 2004
04 Jun 1999